4Moving Biotech upcoming conferences
The official LinkedIn page for the OA-BIO
4Moving Biotech received the Seal of Excellence from
The AWAY DAYS PRECIDIAB INITIATIV
4Moving Biotech Welcomes Luc Boblet as CEO
OA-BIO consortium
PRESS RELEASE
100 startups to invest in 2024
2024 OARSI CONGRESS
OARSI CONGRESS
JPMWeek 2024
Scientific Advisory Board
LASARE Phase I clinical trial
CHINA Bio
APPOINTMENT
Prix Galien US 2023
OARSI 2023
Gordon Research Conference
The second annual meeting of the European OA-BIO
The 35th SFR congress
Fondation Arthritis
The 9th edition of the "GALA de la Fondation"
First-Patient-In Phase I clinical trial in OA
4Moving Biotech celebrates the World Arthritis Day
Pr. Francis Berenbaum was in "La Minute Rhumato"
4Moving Biotech obtains regulatory authorization
4Moving Biotech at eCM
OA-BIO European consortium met in Paris
4Moving Biotech at EULAR 2022
4Moving Biotech at OARSI 2022
4P004-phase-II-in-silico-simulation
4Moving Biotech’s scientific review
The OA-BIO European consortium presents its logo
4Moving Biotech's paper in Scientific Reports
Happy New Year 2022!
4Moving Biotech at the 34th congress of the SFR
4Moving Biotech at EULAR 2021
The OA-BIO European Consortium
4Moving Biotech announces a closing of €2M
4Moving Biotech at the OARSI Connect 2021 online
(Article in French) 4Moving Biotech au congrès SFR
4P-Pharma will present 4P004 data at ACR Convergence
4P-Pharma presents 4P-004 data at the ACR/ARP...